EcoDrugPlus

Sucrase-Isomaltase

Ensembl ID : ENSBGRG00000010109
Gene Symbol: SI
1 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSBGRG00000022811
Gene Symbol: SNCA
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSBGRG00000006090
Gene Symbol: TACR1
1 Cross references
271 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSBGRG00000013194
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSBGRG00000004143
Gene Symbol: TACR3
1 Cross references
258 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSBGRG00000007850
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSBGRG00000001023
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSBGRG00000020972
Gene Symbol: TBXA2R
1 Cross references
194 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSBGRG00000009917
Gene Symbol: THRB
1 Cross references
393 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSBGRG00000005037
Gene Symbol: TRHR
1 Cross references
269 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSBGRG00000017549
Gene Symbol: TLR2
1 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSBGRG00000010229
Gene Symbol: TLR4
1 Cross references
127 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).